Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma
Authors:
- Merrick I. RossMRMerrick I. Ross
- Douglas S. ReintgenDRDouglas S. Reintgen
- R. Dirk NoyesRNR. Dirk Noyes
- James S. GoydosJGJames S. Goydos
- Peter D. BeitschPBPeter D. Beitsch
- Marshall M. UristMUMarshall M. Urist
- Stephan AriyanSAStephan Ariyan
- B. Scott DavidsonBDB. Scott Davidson
- Jeffrey J. SussmanJSJeffrey J. Sussman
- Michael J. EdwardsMEMichael J. Edwards
- Robert C.G. MartinRMRobert C.G. Martin
- 20 June 2006
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (18) , 2849-2857
Abstract
Purpose: To evaluate the prognostic significance of molecular staging using reverse transcriptase polymerase chain reaction (RT-PCR) in detecting occult melanoma cells in sentinel lymph nodes (SLNs) and circulating bloodstream.Patients and Methods: In this multicenter study, eligibility criteria included patient age 18 to 71 years, invasive melanoma ≥ 1.0 mm Breslow thickness, and no clinical evidence of metastasis. SLN biopsy and wide excision of the primary tumor were performed. SLNs were examined by serial-section histopathology and S-100 immunohistochemistry. A portion of each SLN was frozen for RT-PCR. In addition, RT-PCR was performed on peripheral-blood mononuclear cells (PBMCs). RT-PCR analysis was performed using four markers: tyrosinase, MART1, MAGE3, and GP-100. Disease-free survival (DFS), distant–DFS (DDFS), and overall survival (OS) were analyzed.Results: A total of 1,446 patients with histologically negative SLNs underwent RT-PCR analysis. At a median follow-up of 30 months, there was no difference in DFS, DDFS, or OS between the RT-PCR–positive (n = 620) and RT-PCR–negative (n = 826) patients. Analysis of PBMC from 820 patients revealed significant differences in DFS and DDFS, but not OS, for patients with detection of more than one RT-PCR marker in peripheral blood.Conclusion: In this large, prospective, multi-institutional study, RT-PCR analysis on SLNs and PBMCs provides no additional prognostic information beyond standard histopathologic analysis of SLNs. Detection of more than one marker in PBMC is associated with a worse prognosis. RT-PCR remains investigational and should not be used to direct adjuvant therapy at this time.Keywords
This publication has 44 references indexed in Scilit:
- Multimarker Quantitative Real-Time PCR Detection of Circulating Melanoma Cells in Peripheral Blood: Relation to Disease Stage in Melanoma PatientsClinical Chemistry, 2005
- Molecular Staging in Stage II and III Melanoma Patients and Its Effect on Long-Term SurvivalJournal of Clinical Oncology, 2005
- Pathologic Assessment of Melanoma Sentinel Nodes: A Role for Molecular Analysis Using Quantitative Real-Time Reverse Transcription-PCR for MART-1 and Tyrosinase Messenger RNAClinical Cancer Research, 2005
- Serial Follow-Up and the Prognostic Significance of Reverse Transcriptase-Polymerase Chain Reaction—Staged Sentinel Lymph Nodes From Melanoma PatientsJournal of Clinical Oncology, 2004
- Lessons learned from the Sunbelt Melanoma TrialJournal of Surgical Oncology, 2004
- Patterns of Recurrence in Patients with Melanoma and Histologically Negative But RT-PCR-Positive Sentinel Lymph NodesJournal of the American College of Surgeons, 2003
- Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?Annals of Surgical Oncology, 2001
- Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2000
- Role for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Thick (?4 mm) Primary MelanomaAnnals of Surgical Oncology, 2000
- The randomization and stratification of patients to clinical trialsJournal of Chronic Diseases, 1974